8-K: Knowles Q3 2025 Earnings Beat Expectations, Boosts Outlook

Knowles Corporation reported strong third-quarter 2025 financial results, exceeding guidance with a 7% year-over-year revenue increase and a positive outlook for continued growth.

Summary

• Revenues from continuing operations increased 7% year-over-year to $152.9 million in Q3 2025, surpassing the guided range.
• Non-GAAP diluted earnings per share from continuing operations rose 22.2% year-over-year to $0.33, also above the guided range.
• Net cash provided by operating activities was $29.1 million, at the high-end of the guided range.
• The company repurchased $20 million in shares and reduced debt by $15 million during the quarter.
• Precision Devices segment revenue grew 11.9% year-over-year to $88.2 million, with Adjusted EBITDA margins expanding by 200 basis points to 25.7%.
• MedTech & Specialty Audio segment revenue increased 1.6% year-over-year to $64.7 million, though Adjusted EBITDA margins slightly decreased by 40 basis points to 43.7% due to unfavorable product mix.
• For Q4 2025, Knowles expects revenues from continuing operations between $151 million and $161 million, and Non-GAAP diluted EPS between $0.33 and $0.37.
• Full-year 2025 organic revenue growth is projected at 6%, with 2026 organic growth expected at the high end of the 4-6% range.

Sentiment

Score: 8

Explanation: The company delivered strong Q3 2025 results, exceeding guidance for key financial metrics. It demonstrated effective capital allocation through share repurchases and debt reduction. The outlook for Q4 2025 and organic growth for 2025 and 2026 is positive, indicating continued momentum in its target markets. While net cash from operations was down YoY, the overall financial health and strategic execution are strong.

Positives

• Q3 2025 revenues from continuing operations increased 7% year-over-year to $152.9 million, exceeding the guided range.
• Non-GAAP diluted EPS from continuing operations grew 22.2% year-over-year to $0.33, surpassing the guided range.
• Net cash provided by operating activities of $29.1 million was at the high-end of the guided range.
• Repurchased $20 million in shares and reduced debt by $15 million in Q3 2025, demonstrating strong capital allocation.
• Precision Devices segment showed robust growth with revenues up 11.9% year-over-year and Adjusted EBITDA margins improving by 200 basis points.
• Strong design activity and backlog indicate continued growth, with full-year 2025 organic revenue growth projected at 6%.
• Anticipates organic growth at the high end of 4-6% for 2026, driven by new design wins and a healthy backlog.
• Net debt leverage ratio of 0.6x as of September 30, 2025, indicates a healthy balance sheet.

Negatives

• Net cash provided by operating activities in Q3 2025 was $29.1 million, a decrease from $52.8 million in Q3 2024.
• MedTech & Specialty Audio Adjusted EBITDA margins were down slightly by 40 basis points year-over-year, driven by unfavorable product mix.
• Precision Devices segment experienced higher production costs and lower than expected yields associated with the ramp-up of the specialty film product line, partially offsetting margin improvements.

Risks

• Inability to achieve expected strategic and financial benefits from the Consumer MEMS Microphones (CMM) divestiture.
• Fluctuations in stock market price, operating results, and cash flows.
• Challenges in preventing or promptly remedying quality issues in products.
• Risks associated with increasing inventories in advance of anticipated customer orders.
• Global economic instability, including inflation, rising interest rates, pandemics, and geopolitical uncertainties.
• Impact of changes to laws and regulations affecting product and service offerings.
• Ability to achieve planned reductions in operating expenses.
• Challenges in qualifying products and facilities with customers.
• Ability to obtain, enforce, defend, or monetize intellectual property rights.
• Disruption caused by cybersecurity incidents, including cyber-attacks or data breaches.
• Increases in costs or availability issues of critical raw materials and components.
• Difficulties in managing new product ramps and introductions for customers.
• Dependence on a limited number of large customers.
• Increasing competition and new entrants in the market for products.
• Ability to develop new or enhanced products or technologies in a timely manner that achieve market acceptance.
• Escalating international trade tensions, new or increased tariffs, and trade wars.
• Financial risks, including currency fluctuations, credit risks, and market value fluctuations.
• Potential impairment of intangible or long-lived assets due to a sustained decline in stock price and market capitalization.
• Market risk associated with fluctuations in commodity prices, particularly for precious metals used in manufacturing.
• Changes in tax laws, tax rates, and exposure to additional tax liabilities.

Future Outlook

For the fourth quarter ending December 31, 2025, Knowles Corporation anticipates revenues from continuing operations to be between $151 million and $161 million. Non-GAAP diluted earnings per share from continuing operations are projected to be in the range of $0.33 to $0.37, with net cash provided by operating activities expected between $30 million and $40 million. The company is confident in achieving full-year organic revenue growth of 6% in 2025. Looking ahead to 2026, organic growth is expected to be at the high end of the 4-6% range, driven by new design wins and a strong backlog. MedTech & Specialty Audio Adjusted EBITDA margins are expected to be in the low 40% range for the full year 2025.

Management Comments

• "We continued to deliver on expectations in the third quarter of 2025 with revenues, cash provided by operating activities, and non-GAAP diluted EPS from continuing operations all above the mid-point of our guided range."
• "Our cash generated by operating activities in the quarter was again strong, allowing us to repurchase $20 million in shares and reduce debt by $15 million."
• "Our business units continue to execute on our strategy, demonstrated by another quarter of sequential and year over year revenue growth."
• "As we enter the fourth quarter, our design activity and backlog remain strong, and we believe this points to continued growth, giving me confidence in our ability to achieve full year organic revenue growth of 6% in 2025."
• "As we look to next year, with new design wins ramping and a very healthy backlog of existing orders, we expect to see organic growth at the high end of the range of 4-6% for the company."
• "Knowles continues to leverage its unique technologies, creating custom products through our customer application intimacy, and then scaling into production with our world class operational capabilities for end markets with strong secular growth trends."
• "I am excited about the opportunities we have in front of us and with the momentum and strength of the business I continue to be confident in our ability to drive value for our shareholders."

Industry Context

Knowles Corporation operates in specialized electronic components, serving high-growth, stable end markets such as medtech, defense, and industrial. The strong performance, particularly in the Precision Devices segment with increased demand for ceramic capacitors and RF microwave products, aligns with the ongoing robust demand in these sectors, which are often less susceptible to broader economic fluctuations compared to consumer electronics. The company's strategy of leveraging unique technologies and custom products for these markets positions it favorably for sustained growth, as evidenced by the positive organic growth outlook for 2025 and 2026.

Stakeholder Impact

• Shareholders: Benefit from strong financial performance, share repurchases, debt reduction, and a positive future outlook, which could lead to increased shareholder value.
• Employees: Benefit from continued business growth and stability, potentially leading to job security and opportunities.
• Customers: Benefit from Knowles' focus on custom engineering and scalable manufacturing, ensuring high-performance components for their demanding applications.
• Creditors: Benefit from the company's debt reduction and healthy net debt leverage ratio, indicating strong financial management and ability to meet obligations.

Next Steps

• Continued execution on strategy to leverage unique technologies and scale production for end markets with strong secular growth trends.
• Ramping up new design wins to drive organic growth in 2026.
• Managing production costs and yields, particularly for the specialty film product line in the Precision Devices segment.

Key Dates

Recommendation

Knowles Corporation's Q3 2025 results significantly exceeded guidance, demonstrating robust operational execution and strong demand in its core MedTech, Defense, and Industrial markets. The company's proactive capital management, including $20 million in share repurchases and $15 million in debt reduction, underscores a commitment to shareholder value. With a positive outlook for 6% organic revenue growth in 2025 and high-end 4-6% growth in 2026, driven by new design wins and a healthy backlog, the company is well-positioned for sustained performance. The healthy net debt leverage ratio of 0.6x further strengthens its financial standing. These factors collectively suggest a compelling investment opportunity.

Keywords

Knowles, KN, Q3 2025, Earnings, Financial Results, Specialty Electronic Components, Medtech, Defense, Industrial, Capacitors, RF Filters, Microphones, Speakers, Semiconductor, Organic Growth, EBITDA, EPS